Publication | Open Access
Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases
16
Citations
21
References
2020
Year
Further studies on immunotherapy are needed for patients with active BMs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1